Literature DB >> 6408334

Lung lipid synthesis from acetoacetate and glucose in developing rats in vitro.

P M Sheehan, Y Y Yeh.   

Abstract

Acetoacetate (AcAc) and glucose were compared as energy sources and as precursors for lipid synthesis in the lungs of developing rats. Minced lung tissue was incubated with [3-14C]AcAc or [U-14C]glucose and the oxidation of each substrate to CO2 or its incorporation into tissue lipids was quantified. The highest rates of oxidation were obtained during the first 5 days for AcAc and the first 2 days of life for glucose and oxidation of AcAc was 3-4 times greater than that of glucose at all ages. Throughout postnatal development, the rates of nonsaponifiable lipid, fatty acid and hence total lipid (chloroform/methanol extractable) synthesis from AcAc were 2-3 times those of glucose. The highest rates of total lipid synthesis from AcAc and glucose were observed at birth. Glucose was utilized for glyceride-glycerol synthesis at a higher rate than AcAc. Similar patterns of incorporation of AcAc and glucose into various lipid classes were noted. Of the total lipids synthesized from AcAc and glucose, respectively, phospholipid plus monoglyceride accounted for 64% and 77%, triglyceride 13% and 13%, diglyceride plus cholesterol 11% and 4%, fatty acids 9% and 4%, and cholesteryl esters 3% and 1%. AT birth, the specific activities of all lipids except triglyceride derived from AcAc were greater than those from glucose. Rates of synthesis of all complex lipids declined with age. The results of these experiments demonstrate that AcAc is utilized more readily than glucose for energy production and lipid synthesis in developing rat lungs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408334     DOI: 10.1007/BF02534705

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  24 in total

1.  INFLUENCE OF ARTIFICIAL DIET ON WEIGHT GAIN AND BODY COMPOSITION OF THE NEONATAL RAT.

Authors:  H A Dymsza; D M Czajka; S A Miller
Journal:  J Nutr       Date:  1964-10       Impact factor: 4.798

2.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

3.  Fetal utilization of maternally derived ketone bodies for lipogenesis in the rat.

Authors:  D W Seccombe; P G Harding; F Possmayer
Journal:  Biochim Biophys Acta       Date:  1977-09-28

4.  Lipid synthesis by rat lung in vitro.

Authors:  M C Wang; H C Meng
Journal:  Lipids       Date:  1972-03       Impact factor: 1.880

Review 5.  Metabolism of phospholipids in the lung.

Authors:  L M Van Golde
Journal:  Am Rev Respir Dis       Date:  1976-11

Review 6.  Perspectives on fetal lung development.

Authors:  R H Perelman; M J Engle; P M Farrell
Journal:  Lung       Date:  1981       Impact factor: 2.584

7.  Fatty acid synthesis in the perfused rat lung.

Authors:  K F Buechler; R A Rhoades
Journal:  Biochim Biophys Acta       Date:  1980-08-11

8.  Insulin, a possible regulator of ketosis in newborn and suckling rats.

Authors:  Y Y Yeh; P Zee
Journal:  Pediatr Res       Date:  1976-03       Impact factor: 3.756

9.  De novo fatty acid synthesis in developing rat lung.

Authors:  W M Maniscalco; J N Finkelstein; A B Parkhurst
Journal:  Biochim Biophys Acta       Date:  1982-04-15

10.  Relative utilization of fatty acids for synthesis of ketone bodies and complex lipids in the liver of developing rats.

Authors:  Y Y Yeh; V L Streuli; P Zee
Journal:  Lipids       Date:  1977-04       Impact factor: 1.880

View more
  2 in total

1.  Pathways of acetyl CoA production for lipogenesis from acetoacetate, beta-hydroxybutyrate, pyruvate and glucose in neonatal rat lung.

Authors:  P M Sheehan; Y Y Yeh
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

2.  Pulmonary surfactant lipid synthesis from ketone bodies, lactate and glucose in newborn rats.

Authors:  P M Sheehan; Y Y Yeh
Journal:  Lipids       Date:  1985-12       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.